 |
Yanjing Zhu
Visiting Research Scholar Email: Yanjing.Zhu@stonybrookmedicine.edu |
Yanjing Zhu received her Bachelor’s degree in Medicine from the Clinical College of Weifang Medical University in 2012 and is a PhD candidate at Tongji University, China. She is completing her graduate studies at Stony Brook University, having received a scholarship from the China Scholarship Council.
Yanjing’s current project focuses on the development of novel drug combinations for the treatment of lung and pancreatic cancer.
Selected Publications
- Zhu Y, Wu Y, Zhang H, Wang Z, Wang S, Qian Y, Zhu R. Enhanced Anti-Metastatic Activity of Etoposide Using Layered Double Hydroxide Nano Particles. Journal of Biomedical Nanotechnology. 2015;11(12):2158-68.
- Zhu R, Wang Q, Zhu Y, Wang Z, Zhang H, Wu B, Wu X, Wang S. pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer. Acta Biomaterialia. 2016;29:320-32.
- Zhu R, Zhu Y, Zhang M, Xiao Y, Du X, Liu H, Wang S. The induction of maturation on dendritic cells by TiO2 and Fe(3)O(4)@TiO(2) nanoparticles via NF-kappaB signaling pathway. Materials Science & Engineering C, Materials for Biological Applications. 2014;39:305-14.
- Wang J, Zhu R, Sun X, Zhu Y, Liu H, Wang SL. Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway. International Journal of Nanomedicine. 2014;9:3987-98.
For a complete list of publications, Click Here.
